Bernstein Maintains Outperform Rating on Kelun-Biotech
Bernstein maintained its Outperform rating on Kelun-Biotech.
Related stories
Kingsgate Consolidated Reports Quarterly Gold and Silver Sales
Kingsgate Consolidated reported gold sales of 17,339 ounces and silver sales of 211,081 ounces for the quarter.
M impact | EQUITY | Oct 30, 2026, 01:46 AM UTC
Kingsgate Consolidated Produces 14,802 Ounces of Gold and 187,925 Ounces of Silver
The company reported an all-in sustaining cost of US$1,547 per ounce and said the metals were sold in the quarter.
L impact | EQUITY | Oct 30, 2026, 01:46 AM UTC
China’s Xinyi Sheng Drops 15.1% as Q3 Net Profit Falls
Xinyi Sheng shares fell as much as 15.1% Friday morning after its third-quarter net profit declined nearly one-fifth quarter over quarter.
M impact | EQUITY | Oct 30, 2026, 01:45 AM UTC
Mastercard Shares Rise More Than 4% After Q3 Results Beat Expectations
Mastercard shares gained more than 4% at Thursday’s close, reached a 52-week high of $641.56 during regular trading and logged their best session since January.
M impact | EQUITY | Oct 30, 2026, 01:45 AM UTC
Hyundai Glovis Q3 Operating Profit Rises 8.1%
Hyundai Glovis reported an 8.1% year-on-year rise in third-quarter operating profit.
M impact | EQUITY | Oct 30, 2026, 01:45 AM UTC
InnoLight Hong Kong shares hit record low, fall as much as 7.6%
InnoLight’s Hong Kong shares opened 7.1% lower Friday and fell as much as 7.6% intraday, setting a record low as the market digested its results.
M impact | EQUITY | Oct 30, 2026, 01:42 AM UTC